SLC35F5
gene geneOn this page
Also known as FLJ22004
Summary
SLC35F5 (solute carrier family 35 member F5, HGNC:23617) is a protein-coding gene on chromosome 2q14.1, encoding Solute carrier family 35 member F5 (Q8WV83). Putative solute transporter.
Predicted to be located in membrane.
Source: NCBI Gene 80255 — RefSeq curated summary.
At a glance
- Gene–disease (curated): multiple congenital anomalies/dysmorphic syndrome (Limited, GenCC)
- GWAS associations: 4
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_025181
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23617 |
| Approved symbol | SLC35F5 |
| Name | solute carrier family 35 member F5 |
| Location | 2q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22004 |
| Ensembl gene | ENSG00000115084 |
| Ensembl biotype | protein_coding |
| OMIM | 619997 |
| Entrez | 80255 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 18 protein_coding, 6 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000245680, ENST00000409106, ENST00000409342, ENST00000420066, ENST00000447673, ENST00000459683, ENST00000460863, ENST00000469314, ENST00000469702, ENST00000470204, ENST00000485214, ENST00000498768, ENST00000889529, ENST00000889530, ENST00000889531, ENST00000889532, ENST00000889533, ENST00000889534, ENST00000913632, ENST00000950464, ENST00000950465, ENST00000950466, ENST00000950467, ENST00000950468, ENST00000950469, ENST00000950470, ENST00000950471
RefSeq mRNA: 5 — MANE Select: NM_025181
NM_001330314, NM_001330315, NM_001330316, NM_001330317, NM_025181
CCDS: CCDS2119, CCDS82503, CCDS86878
Canonical transcript exons
ENST00000245680 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001162097 | 113756370 | 113756642 |
| ENSE00001726841 | 113729401 | 113729505 |
| ENSE00001744025 | 113731584 | 113731648 |
| ENSE00001779762 | 113734586 | 113734673 |
| ENSE00001786368 | 113735777 | 113735858 |
| ENSE00001885632 | 113706709 | 113715195 |
| ENSE00002158334 | 113742692 | 113742879 |
| ENSE00003458423 | 113725378 | 113725537 |
| ENSE00003465846 | 113755165 | 113755306 |
| ENSE00003501472 | 113743713 | 113743794 |
| ENSE00003535696 | 113750425 | 113750568 |
| ENSE00003561362 | 113719154 | 113719308 |
| ENSE00003602483 | 113723104 | 113723194 |
| ENSE00003624358 | 113717753 | 113717850 |
| ENSE00003657378 | 113746277 | 113746339 |
| ENSE00003665441 | 113755454 | 113755544 |
Expression profiles
Bgee: expression breadth ubiquitous, 271 present calls, max score 98.99.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.8095 / max 540.9090, expressed in 1823 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 30334 | 18.3524 | 1806 |
| 30335 | 14.9680 | 1792 |
| 30333 | 3.3395 | 1522 |
| 30332 | 0.9758 | 435 |
| 30331 | 0.1739 | 56 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 98.99 | gold quality |
| parietal pleura | UBERON:0002400 | 97.00 | gold quality |
| jejunal mucosa | UBERON:0000399 | 96.96 | gold quality |
| tibia | UBERON:0000979 | 96.93 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.90 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.88 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 96.86 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.76 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.61 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.47 | gold quality |
| adrenal gland | UBERON:0002369 | 96.46 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.24 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 96.11 | gold quality |
| body of pancreas | UBERON:0001150 | 95.97 | gold quality |
| colonic mucosa | UBERON:0000317 | 95.95 | gold quality |
| visceral pleura | UBERON:0002401 | 95.78 | gold quality |
| stromal cell of endometrium | CL:0002255 | 95.72 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.55 | gold quality |
| rectum | UBERON:0001052 | 95.43 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 95.35 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.23 | gold quality |
| upper leg skin | UBERON:0004262 | 95.17 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.99 | gold quality |
| retina | UBERON:0000966 | 94.96 | gold quality |
| gall bladder | UBERON:0002110 | 94.81 | gold quality |
| oral cavity | UBERON:0000167 | 94.59 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 94.59 | gold quality |
| pleura | UBERON:0000977 | 94.48 | gold quality |
| heart right ventricle | UBERON:0002080 | 94.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
135 targeting SLC35F5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc35f5 | ENSMUSG00000026342 |
| rattus_norvegicus | Slc35f5 | ENSRNOG00000003403 |
| drosophila_melanogaster | CG8195 | FBGN0034032 |
| caenorhabditis_elegans | B0041.5 | WBGENE00015009 |
Protein
Protein identifiers
Solute carrier family 35 member F5 — Q8WV83 (reviewed: Q8WV83)
Alternative names: Hepatitis C virus NS5A-transactivated protein 3
All UniProt accessions (5): B8ZZV6, B8ZZY4, H7C0S5, H7C2I7, Q8WV83
UniProt curated annotations — full annotation on UniProt →
Function. Putative solute transporter.
Subcellular location. Membrane.
Tissue specificity. Expressed in colorectal cancer cells.
Similarity. Belongs to the SLC35F solute transporter family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WV83-1 | 1 | yes |
| Q8WV83-2 | 2 |
RefSeq proteins (5): NP_001317243, NP_001317244, NP_001317245, NP_001317246, NP_079457* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR037185 | EmrE-like | Homologous_superfamily |
UniProt features (18 total): transmembrane region 10, splice variant 4, chain 1, domain 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WV83-F1 | 72.79 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 207
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 134 (showing top):
TTTGTAG_MIR520D, SP1_Q2_01, KIM_GERMINAL_CENTER_T_HELPER_UP, ATF4_Q2, TGCCTTA_MIR124A, chr2q14, ATF_01, CREB_01, LIU_SOX4_TARGETS_DN, NUYTTEN_NIPP1_TARGETS_DN, MATSUDA_NATURAL_KILLER_DIFFERENTIATION, CHEN_LIVER_METABOLISM_QTL_CIS, ELF2_TARGET_GENES, KAT2A_TARGET_GENES, LMTK3_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
828 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC35F5 | SLC35G2 | Q8TBE7 | 535 |
| SLC35F5 | SLC10A7 | Q0GE19 | 479 |
| SLC35F5 | SLC22A15 | Q8IZD6 | 472 |
| SLC35F5 | DCDC2B | A2VCK2 | 408 |
| SLC35F5 | SLC35B4 | Q969S0 | 407 |
| SLC35F5 | SLC7A2 | P52569 | 404 |
| SLC35F5 | SLC19A2 | O60779 | 404 |
| SLC35F5 | SLC35H1 | Q9NQQ7 | 404 |
| SLC35F5 | SMAP1 | Q8IYB5 | 400 |
| SLC35F5 | SLC35D3 | Q5M8T2 | 388 |
| SLC35F5 | SLC39A13 | Q96H72 | 383 |
| SLC35F5 | SLC35D2 | Q76EJ3 | 376 |
| SLC35F5 | SLC35G1 | Q2M3R5 | 372 |
| SLC35F5 | SLC35E1 | Q96K37 | 372 |
| SLC35F5 | SLC43A3 | Q8NBI5 | 370 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NIPAL1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.640 |
| CXCR4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| YIPF3 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| C3AR1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| MANSC1 | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| SPINT2 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A9 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| NS3 | C15orf61 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| KCNA2 | TMEM129 | psi-mi:“MI:0914”(association) | 0.350 |
| TTMP | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| TTYH1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| AVPR2 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CTLA4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM74 | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| AVPR1B | KLRG2 | psi-mi:“MI:0914”(association) | 0.350 |
| C5AR1 | TCAF2 | psi-mi:“MI:0914”(association) | 0.350 |
| CX3CL1 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| KCNE3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.350 |
| IL17RB | ATP1A3 | psi-mi:“MI:0914”(association) | 0.350 |
| CXCR4 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| DLK1 | PLPP3 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC35F5 | STX10 | psi-mi:“MI:0914”(association) | 0.350 |
| PLCL2 | SLC35F5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC35F5 | SHOC2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC35F5 | ITGB1BP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (78): SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SHOC2 (Affinity Capture-MS), SLC35F5 (Affinity Capture-MS), SLC35F5 (Affinity Capture-RNA), SLC35F5 (Affinity Capture-MS), SLC35F5 (Proximity Label-MS), SLC35F5 (Proximity Label-MS), SLC35F5 (Proximity Label-MS)
ESM2 similar proteins: A1L272, A6QL92, B8AF63, E2RFJ3, E7EXX2, O35458, O35633, O54902, O80605, P49281, P49282, P51027, P57057, P58355, Q0VA82, Q28CV2, Q569T7, Q5F383, Q5R6J3, Q5RD30, Q5U3U7, Q62052, Q640L2, Q6DEJ6, Q6DIV6, Q6GPQ3, Q6GQE1, Q6P499, Q6PF45, Q6YK44, Q7RTT9, Q8BGN5, Q8BH31, Q8CBH5, Q8MIQ9, Q8NA29, Q8NBI5, Q8NHS3, Q8R070, Q8R139
Diamond homologs: A6QL92, O94654, Q04083, Q4R794, Q5R6J3, Q8R314, Q8WV83, Q03730
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3122 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:113729395:TCTTA:T | donor_loss | 1.0000 |
| 2:113729396:CT:C | donor_loss | 1.0000 |
| 2:113729397:TTA:T | donor_loss | 1.0000 |
| 2:113729398:T:TG | donor_loss | 1.0000 |
| 2:113729399:ACC:A | donor_loss | 1.0000 |
| 2:113729502:GAACC:G | acceptor_loss | 1.0000 |
| 2:113729503:AACC:A | acceptor_loss | 1.0000 |
| 2:113729506:C:CC | acceptor_gain | 1.0000 |
| 2:113729506:C:T | acceptor_loss | 1.0000 |
| 2:113729507:T:A | acceptor_loss | 1.0000 |
| 2:113731579:CTTA:C | donor_loss | 1.0000 |
| 2:113731581:TA:T | donor_loss | 1.0000 |
| 2:113731582:A:C | donor_loss | 1.0000 |
| 2:113731583:C:G | donor_loss | 1.0000 |
| 2:113731583:CCTA:C | donor_gain | 1.0000 |
| 2:113731644:CAATG:C | acceptor_gain | 1.0000 |
| 2:113731647:TG:T | acceptor_gain | 1.0000 |
| 2:113731649:C:CC | acceptor_gain | 1.0000 |
| 2:113735856:CCA:C | acceptor_gain | 1.0000 |
| 2:113735857:CAC:C | acceptor_gain | 1.0000 |
| 2:113735859:C:CC | acceptor_gain | 1.0000 |
| 2:113742723:A:AC | donor_gain | 1.0000 |
| 2:113742724:C:CC | donor_gain | 1.0000 |
| 2:113742881:T:C | acceptor_gain | 1.0000 |
| 2:113743708:CTTA:C | donor_loss | 1.0000 |
| 2:113743709:TTACT:T | donor_loss | 1.0000 |
| 2:113743710:TACTT:T | donor_loss | 1.0000 |
| 2:113743711:A:AC | donor_gain | 1.0000 |
| 2:113743711:A:T | donor_loss | 1.0000 |
| 2:113743712:C:CC | donor_gain | 1.0000 |
AlphaMissense
3437 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:113723193:C:G | G418R | 1.000 |
| 2:113725385:A:G | W415R | 1.000 |
| 2:113725385:A:T | W415R | 1.000 |
| 2:113725529:C:G | G367R | 1.000 |
| 2:113725537:C:T | G364D | 1.000 |
| 2:113729401:C:G | G364R | 1.000 |
| 2:113742710:G:C | S244R | 1.000 |
| 2:113742710:G:T | S244R | 1.000 |
| 2:113742712:T:G | S244R | 1.000 |
| 2:113723149:G:C | S432R | 0.999 |
| 2:113723149:G:T | S432R | 0.999 |
| 2:113723151:T:G | S432R | 0.999 |
| 2:113723183:A:G | L421P | 0.999 |
| 2:113723192:C:T | G418D | 0.999 |
| 2:113725417:C:T | G404D | 0.999 |
| 2:113725418:C:G | G404R | 0.999 |
| 2:113725505:A:G | W375R | 0.999 |
| 2:113725505:A:T | W375R | 0.999 |
| 2:113725528:C:T | G367D | 0.999 |
| 2:113725537:C:A | G364V | 0.999 |
| 2:113735858:A:G | W251R | 0.999 |
| 2:113735858:A:T | W251R | 0.999 |
| 2:113742711:C:A | S244I | 0.999 |
| 2:113742854:G:C | F196L | 0.999 |
| 2:113742854:G:T | F196L | 0.999 |
| 2:113742856:A:G | F196L | 0.999 |
| 2:113755191:A:G | W83R | 0.999 |
| 2:113755191:A:T | W83R | 0.999 |
| 2:113755223:C:T | G72E | 0.999 |
| 2:113755224:C:A | G72W | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000150155 (2:113727165 CTT>C), RS1000194637 (2:113703321 C>G), RS1000225897 (2:113703612 C>T), RS1000282417 (2:113754003 T>C), RS1000290699 (2:113709062 C>A), RS1000342936 (2:113740233 T>A,C), RS1000368312 (2:113715852 T>C), RS1000432476 (2:113747317 G>A), RS1000445130 (2:113716318 C>T), RS1000509265 (2:113745513 G>A), RS1000563283 (2:113702318 C>T), RS1000597353 (2:113706926 A>T), RS1000641897 (2:113756127 T>A,C), RS1000704285 (2:113714152 T>C), RS1000770629 (2:113745823 G>A)
Disease associations
OMIM: gene MIM:619997 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| multiple congenital anomalies/dysmorphic syndrome | Limited | Autosomal recessive |
Mondo (1): multiple congenital anomalies/dysmorphic syndrome (MONDO:0019042)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90020025_1550 | Waist-to-hip ratio adjusted for BMI | 1.000000e-09 |
| GCST90020027_90 | Waist-hip index | 5.000000e-10 |
| GCST90020027_91 | Waist-hip index | 2.000000e-08 |
| GCST90020029_509 | Waist circumference adjusted for body mass index | 8.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC35 family of nucleotide sugar transporters
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases methylation, increases expression | 3 |
| Cadmium | increases expression, increases response to substance, increases abundance | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| urushiol | increases expression | 1 |
| alpha-pinene | increases abundance, affects cotreatment, increases oxidation | 1 |
| o,p’-DDT | increases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| potassium chromate(VI) | decreases expression, affects cotreatment | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Air Pollutants | increases abundance, increases oxidation, affects cotreatment | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Fluorouracil | affects response to substance | 1 |
| Formaldehyde | increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | increases abundance, affects cotreatment, increases oxidation | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Quercetin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4F4 | 1321N1-SLC35F5-KO-c10 | Cancer cell line | Male |
| CVCL_D4F5 | 1321N1-SLC35F5-KO-c11 | Cancer cell line | Male |
| CVCL_TN29 | HAP1 SLC35F5 (-) 1 | Cancer cell line | Male |
| CVCL_XT26 | HAP1 SLC35F5 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: multiple congenital anomalies/dysmorphic syndrome
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): multiple congenital anomalies/dysmorphic syndrome